drugset / Trial / NCT04703868
A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
A study to compare the safety, pharmacokinetics and pharmacodynamics of YPI 011 to Rabeprazole in healthy adult subjects
Timeline
- Start
- 2021-01-13
- Primary completion
- 2021-06-01
- Completion
- 2021-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 10 mg | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |